Vistin Pharma ASA : Energy trading business to commence operations

Oslo, Norway, 8 May 2018

Reference is made to the announcements from Vistin Pharma ASA on 16 March and 22 March regarding the development of a new business area within energy trading. At the annual general meeting held today the shareholders approved the required changes to the articles of association. The shareholders also approved the private placement of NOK 300 million in gross proceeds completed on 22 March, to fund the establishment of the energy trading business and trading activities within this area. Part of Vistin Pharma's strategy is to invest in asymmetrical investment opportunities caused by fundamental changes in the oil space, and the Company is now in a position to commence its trading activities. Vistin Pharma plans to invest in energy related financial instruments in the near future, which is expected to create a significant financial exposure. The total financial exposure of these investments will not exceed the capital raised to fund the energy trading activity. All trading activities will be carried out through the wholly owned subsidiary Vistin Trading AS.

For further information, please contact:

Kjell-Erik Nordby
CEO
+47 91 36 42 80
kjell-erik.nordby@vistin.com

Gunnar Manum
CFO
+47 95 17 91 90
gunnar.manum@vistin.com

 
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.